Young Ambassador Programme

/Young Ambassador Programme
Young Ambassador Programme 2018-01-15T20:30:01+00:00

Medical oncologist in hematology and BMT unit in National Medical Research center of oncology named after N.N. Petrov, Russia

Evgeniya has worked in haematology and BMT unit since graduated residency in 2015. She is involved in scientific work on different treatment approaches in high-grade B-cell lymphoma with MYC, BCL-2 and/or BCL-6 rearrangements. In 2017 she obtained International Development Education Award (IDEA) provided by the ASCO and her mentor in this program has been Professor John Sweetenham, Huntsman Cancer Hospital, University of Utah, USA. She is also fully granted as visiting scholar in Instituto oncologico della svizzera Italiana (IOSI) in Bellinzona.

Evgeniya is excited to be an EBMT Ambassador and cannot wait to share EBMT values in her country.


4th year medical student, American University of Beirut (AUB), Beirut, Lebanon

Abdul Hamid Bazarbachi was born in Paris, France and he is currently a 4th year medical student at the American University of Beirut (AUB). He was determined to pursue a career in medicine for as long as he can remember and has been very interested in the field of hematology – oncology since his exposure to it at an undergraduate level. He grew more fond of the field as he indulged in basic and later clinical hematological research in the past few years. His professional interests are mainly focused around the field of leukemia and hematopoietic stem cell transplantation and he plans on pursuing his career with significant focus on research as he often likes to ask How? Why? And What if?. On a less professional level, he enjoys pencil drawing and playing the piano.

Abdul Hamid is looking forward to this incredible opportunity to be a part of the EBMT Annual Meeting which he will put his all into and hope to benefit as much as possible from.


Internal Medicine resident physician at University of Minnesota Medical Center, USA

Malvi completed her undergraduate training at Vanderbilt University followed by her medical degree from University of Tennessee. In medical school she developed an interest in hematology and transplant. Her current research involves identifying the utility of specific parameters within routine auto-HSCT PET scans in predicting survival of relapsed DLBCL patients. She is also interested in pursuing further clinical research in the long-term complications after HSCT.
She hopes to enhance her knowledge in the innovative advances in the field of hematology from international leaders and advance her professional and personal growth in the process.


Internal Medicine resident at the Lebanese University, Beirut, Lebanon.

Razan obtained her Medical Degree (MD) in 2015 from the Lebanese University. She obtained a university diploma in medical research from the Foundation of Medical Research Institute in 2016. She embarked on her “Hematology journey” early when she did a rotation in France in February 2015. There, she was introduced to the hematology and bone marrow transplant fascinating world. Her main research interest is BMT and BMT complications. She presented her research at an ASH oral session in 2017 and posters at the EBMT Annual Meeting. She attended the EBMT Annual Meeting 2017 in Marseille where she got the opportunity to meet with many mentors and pioneers and young ambassadors.

She says: “I am happy to be part of this society. Sharing knowledge and novelties in hematology and BMT is essential for advancing the field and achieving cure to our patients. I am looking forward to see you all in Lisbon.”


Final year medical student at Newcastle University, UK.

Catherine is in her final year of medicine at Newcastle University and is currently on placement in hospitals all around scenic Northumberland. She has loved all aspects of the medical school curriculum but has been particularly fascinated by immunology, notably the clinical applications for patients. She says ‘I find it fascinating how such a simple yet genius concept – that of transferring stem cells from an altruistic donor to a critically ill patient – has transformed, and continues to transform lives for the better’. Following her enjoyment of a 6-week paediatric immunology placement she decided to take a year out of clinical medicine to study for a MRes Immunobiology. Her research explored the effects of ECP for acute GvHD in paediatric patients, focussing specifically on changes in cytokines.


Bacc. med. techn., Bone marrow transplant unit, Department of Internal Medicine, University Hospital Centre Zagreb, Croatia

Dzenana Dzaferagic is Bacc. med. techn., with more than 14 years of experience, working and specialising in Bone marrow transplant unit at the University Hospital Centre Zagreb. She is motivated and interested in learning, especially in the field of late effects and quality of life after allogeneic stem cell transplantation. She was pleased to attend the EBMT 2017 in Marseille, poster session, with pilot study investigating sexual dysfunction in patients after stem cell transplantation in Croatia. She has designed a brochure for patients, regarding some sexual problems they might have during the treatment and after discharge from hospital and with some solutions how to improve their sexual functioning after stem cell transplantation.

Physician and PhD student of the Molecular Medicine program of the University of Perugia, Italy

Sara got her M.D. degree in 2010 from the University of Perugia. She completed her training in haematology in 2016 at the division of Haematology and Blood and Marrow Transplantation. Her main research interests are hematopoietic stem cell transplantation, regulatory T cell biology and CAR-T cell therapy. The Perugia BMT centre pioneered HLA-haploidentical hematopoietic stem cell transplantation for leukaemia patients without a matched donor. During her training she was actively involved in an innovative trial of haploidentical transplantation with regulatory and conventional T cell adoptive immunotherapy. She is currently investigating B-cell reconstitution in preclinical models and in patients after transplantation and innovative strategies of immunotherapy with CAR-T cells.


Hematologist at the Hospital São João, Porto, Portugal

Teresa Garrido received her Medical Degree from the University of Coimbra (Portugal). In 2011, she started the residency training in Hematology at the Hospital São João. She won a scholarship from the Portuguese Hematology Society and had the opportunity to perform an internship in Stem Cell Transplantation at the Hospital Clínic, in Barcelona (Spain), where she conducted a study that was presented at the EBMT 2015 Annual Meeting in Istanbul. She concluded her residency and currently works at the Hemato-Oncology ward in Hospital São João. Her interests, besides SCT, include Hodgkin’s and aggressive Non Hodgkin’s lymphomas, as well as acute leukemias. She is both honoured and excited to be an EBMT Young Ambassador, and is eager to meet and learn from the best in the beautiful city of Lisbon.


2nd year of residency at University Hospital Zagreb, currently a special volunteer at the National Institutes of Health, Bethesda, USA

Ana Zelic Kerep obtained her medical degree at University of Zagreb School of Medicine. After medical internship, she acquired clinical experience working as a family doctor. In 2015, she gained a hematology residency position at University Hospital Center Zagreb. Currently she is doing research on chronic GVHD at National Institutes of Health, Bethesda, USA. After return to Croatia she will pursue a doctoral degree. Her interests are clinical and biological determinants of chronic GVHD, cGVHD immunology and biomarker research.


Hematology and Oncology fellow, Weill Cornell Medicine/New York Presbyterian Hospital, New York.

Alexandra received her medical degree from Universidad de Los Andes in Bogota, Colombia. After completing her training, she decided to move to the US for her specialty training. She completed her Internal Medicine degree at the University of Miami/Jackson Memorial Hospital and she is currently a second-year Hematology & Oncology Fellow at Weill Cornell Medicine. She has had a long term interest and passion for Bone Marrow Transplantation. Her current research interests include methodologies and applicabilities of measuring Minimal Residual Disease in AML after transplant. She aspires to continue her training with an advance fellowship in BMT and to continue to grow as a junior investigator.